Colfosceril palmitate
Clinical data | |
---|---|
Trade names | Exosurf |
AHFS/Drugs.com | International Drug Names |
ATC code | R07AA01 (WHO) |
Identifiers | |
| |
Synonyms | [2-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium |
CAS Number | 63-89-8 |
PubChem (CID) | 6138 |
ChemSpider | 5908 |
UNII | 319X2NFW0A |
KEGG | D03585 |
ChEMBL | CHEMBL1200737 |
ECHA InfoCard | 100.000.516 |
Chemical and physical data | |
Formula | C40H80NO8P |
Molar mass | 734.039 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.[1] It is a drug that is used in surfactant deficient conditions such as IRDS in newborns.
See also
References
- ↑ Rubin, B. K. (1996). "Therapeutic aerosols and airway secretions". Journal of Aerosol Medicine. 9 (1): 123–130. doi:10.1089/jam.1996.9.123. PMID 10160202.
This article is issued from Wikipedia - version of the 7/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.